Jushi Holdings (JUSHF) Capital Expenditures (2021 - 2026)
Jushi Holdings (JUSHF) posted quarterly Capital Expenditures of $3.9 million for Q2 2026, down 5.39% year-over-year from $4.1 million in Q2 2025, and up 28.35% quarter-over-quarter from $3.0 million in Q1 2026.
Jushi Holdings (JUSHF) Capital Expenditures (2021 - 2026) Analysis & Trends
Jushi Holdings (JUSHF) has reported Capital Expenditures for 6 consecutive years, with $3.9 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Capital Expenditures fell 5.39% year-over-year to $3.9 million; the TTM figure through Jun 2026 stood at $14.9 million (up 34.29% YoY), while the FY2025 annual figure was $16.1 million, up 241.76% from the prior year.
- Capital Expenditures improved to $3.9 million in Q2 2026 per JUSHF's latest filing, from $3.0 million in the prior quarter.
- Across five years, Capital Expenditures topped out at $24.9 million in Q1 2022 and bottomed at $687000.0 in Q2 2024.
- Historically, Capital Expenditures has averaged $5.3 million across 5 years, with a median of $3.5 million in 2025.
- Annual changes were most pronounced in 2023 — Capital Expenditures plunged 89.97% — and 2025, when it soared 531.95%.
- Jushi Holdings' Capital Expenditures stood at $7.7 million in 2022, then tumbled by 69.18% to $2.4 million in 2023, then fell by 7.8% to $2.2 million in 2024, then soared by 42.0% to $3.1 million in 2025, then advanced by 26.14% to $3.9 million in 2026.
- Business Quant data shows JUSHF's Capital Expenditures at $3.9 million in Q2 2026, $3.0 million in Q1 2026, and $3.1 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 104.00 Mn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 117.00 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -337.60 Mn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 108.00 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 52.80 Mn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 7.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 33.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Jushi Holdings | 83.87 Mn | 50.54 Mn | 31.53 Mn | 3.89 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3.89 Mn |
| Jun 30, 2026 | 3.89 Mn |
| Mar 31, 2026 | 3.03 Mn |
| Mar 31, 2026 | 3.03 Mn |
| Dec 31, 2025 | 3.09 Mn |
| Dec 31, 2025 | 3.09 Mn |
| Sep 30, 2025 | 4.87 Mn |
| Sep 30, 2025 | 4.87 Mn |
| Jun 30, 2025 | 4.12 Mn |
| Jun 30, 2025 | 4.12 Mn |
| Mar 31, 2025 | 4.02 Mn |
| Mar 31, 2025 | 4.02 Mn |
| Dec 31, 2024 | 2.17 Mn |
| Dec 31, 2024 | 2.17 Mn |
| Sep 30, 2024 | 770,000.00 |
| Sep 30, 2024 | 770,000.00 |
| Jun 30, 2024 | 687,000.00 |
| Jun 30, 2024 | 687,000.00 |
| Mar 31, 2024 | 1.08 Mn |
| Mar 31, 2024 | 1.08 Mn |